Get access to our best features
Get access to our best features
Published 3 months ago

Twenty-year-olds save artificial pancreas in Goor from ruin after pharmacy refuses to deliver hormone

Summary by tubantia.nl
Last year, diabetic patients saved a trial with the artificial pancreas Inreda AP from Goor. When pharmaceutical company Novo Nordisk refused to supply the essential hormone glucagon any longer, they exchanged leftovers and orders from their own pharmacies. “We would continue, or we would all stop,” says Jolanda Prins.

0 Articles

All
Left
Center
Right
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe
Ground News Article Assistant
Not enough coverage to generate an Article Assistant.

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)